NCT00277147View on ClinicalTrials.gov

Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 9, 2006

Study Completion Date

September 17, 2008

Conditions
Typhoid Fever
Interventions
DRUG

BB IND 6989

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00277147 - Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine | Biotech Hunter | Biotech Hunter